Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Atherosclerosis. 2013 Feb 18;228(1):230–236. doi: 10.1016/j.atherosclerosis.2013.01.046

Table 3.

Association of plasma CETP activity and PLTP activity with incidence of CVD events by sex: results of multivariable Cox regression.

Model Men Women


Hazards ratio (95% CI) P Hazards ratio (95% CI) P
Plasma CETPb as a continuous variable, adjusted for baseline risk factorsa 0.79 (0.64, 0.98) 0.032 1.01 (0.81, 1.27) 0.914
Plasma CETPb as a continuous variable, adjusted for baseline risk factorsa and PLTP 0.80 (0.65, 0.99) 0.036 1.01 (0.81, 1.27) 0.920
Plasma CETP activity as a binary variable, adjusted for baseline risk factorsa and PLTP; hazards ratio for CETP activity ≥median (<median as referent) 0.64 (0.43, 0.95) 0.026 0.94 (0.59, 1.49) 0.789
Plasma PLTPb as a continuous variable, adjusted for baseline risk factorsa 1.20 (1.00, 1.45) 0.046 1.03 (0.81, 1.32) 0.796
Plasma PLTPb as a continuous variable, adjusted for baseline risk factorsa and CETP 1.20 (1.00, 1.44) 0.052 1.03 (0.81, 1.32) 0.799
Plasma PLTP activity as a binary variable, adjusted for baseline risk factorsa and CETP; Hazards Ratio for CETP activity ≥median (<median as referent) 1.64 (1.10, 2.46) 0.016 0.95 (0.60, 1.51) 0.838
CETP/PLTP activity ratiob 0.66 (0.51, 0.87) 0.003 0.97 (0.75, 1.25) 0.806
a

Adjustments: age, smoking, diabetes, obesity (defined as BMI ≥ 30), systolic blood pressure, use of antihypertensive medications, plasma HDL-C, triglycerides, and LDL-C.

b

Hazard ratio is per 1 standard deviation.